Stock SPEX SPEXIS AG
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Spexis AG

Equities

SPEX

CH0106213793

Market Closed - Swiss Exchange
Other stock markets
 09:01:30 26/04/2024 pm IST 		5-day change 1st Jan Change
0.059 CHF +0.34% Intraday chart for Spexis AG +7.27% +43.90%
17/04 Santhera Pharmaceuticals Terminates Cystic Fibrosis Drug License Deal with Spexis MT
17/04 Swiss Court OKs Moratorium Extension for Spexis MT

Chart calendar Spexis AG

fba59869791fe972fe2ab840d8.OVuxON1PSxorW9LJV9WQ1Bqdg8HmeubZz9frvxPg4Qg.dBLcTakFDEMbIpigDpyhrVip1KLUDdWbgeWk5UnRqW5vLfVfjzYYcBsytQ~8b1a198d8626a19607c4c88d2bf4fa91

Upcoming events on Spexis AG

05/09/2024 Q2 2024 Earnings Release (Projected)
21/02/2025 Q4 2024 Earnings Release (Projected)
04/09/2025 Q2 2025 Earnings Release (Projected)

Past events on Spexis AG

09/10/2023 06:00 pm Business Update Call
29/09/2023 10:55 am Q2 2023 Earnings Release
26/06/2023 06:30 pm Annual General Meeting
30/05/2023 10:45 am Q4 2022 Earnings Release
14/11/2022 LSX Investival Showcase
25/10/2022 05:00 pm Bio-Europe Conference
04/10/2022 BioPharm America Conference
28/09/2022 BioPharm America Conference
21/09/2022 Sachs Associates Biotech in Europe Forum
06/09/2022 05:30 pm Interim 2022 Earnings Call
06/09/2022 02:15 pm German Fall Conference
06/09/2022 10:50 am Interim 2022 Earnings Release
28/07/2022 05:30 pm Business Update Call
25/05/2022 12:30 am H.C. Wainwright Global Life Sciences Investment Conference
17/05/2022 BioEquity Europe Conference - One on One
26/04/2022 Annual General Meeting
07/04/2022 06:00 pm Investor Meeting - Pre-AGM Information Call
24/03/2022 07:00 pm FY 2021 Earnings Call
24/03/2022 12:30 pm FY 2021 Earnings Release
14/10/2021 05:30 pm Business Update Call - Pre-EGM Call

Annual results

Fiscal PeriodDecember 2021 2022
Net sales
Million CHF		Released
Forecast
Spread 		0,00


0,00
0,62
-
EBITDA
Million CHF		Released
Forecast
Spread 		0,00


-17,2
-14,4
-19.94%
EBIT
Million CHF		Released
Forecast
Spread 		0,00


-18,7
-15,4
-21.37%
Earnings before Tax (EBT)
Million CHF		Released
Forecast
Spread 		0,00


-18,6
-15,6
-19.24%
Net income
Million CHF		Released
Forecast
Spread 		-11,9


-18,6
-15,6
-19.24%
EPS
CHF		Released
Forecast
Spread 		0,00


-0,38
-0,32
-18.75%
Announcement Date24/03/2230/05/23

Upcoming sector events for Spexis AG

29/04/2024 HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
29/04/2024 SHANGHAI OPM BIOSCIENCES CO., LTD.: Q4 2023 Earnings Release
29/04/2024 CANSINO BIOLOGICS INC.: Q1 2024 Earnings Release
29/04/2024 SHANGHAI JUNSHI BIOSCIENCES CO., LTD.: Q1 2024 Earnings Release
29/04/2024 SINOVAC BIOTECH LTD.: Q4 2023 Earnings Release (Projected)
30/04/2024 SHANGHAI RAAS BLOOD PRODUCTS CO., LTD.: Q1 2024 Earnings Release
30/04/2024 SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.: Q4 2023 Earnings Release
30/04/2024 SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.: Q1 2024 Earnings Release
30/04/2024 BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED: Q4 2023 Earnings Release
30/04/2024 04:30 pm INCYTE CORPORATION: Q1 2024 Earnings Release
More events

Past sector events for Spexis AG

27/04/2024 PACIFIC SHUANGLIN BIO-PHARMACY CO., LTD: Q4 2023 Earnings Release
27/04/2024 BEIJING BOHUI INNOVATION BIOTECHNOLOGY GROUP CO., LTD.: Q1 2024 Earnings Release
27/04/2024 SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.: Q1 2024 Earnings Release
27/04/2024 PACIFIC SHUANGLIN BIO-PHARMACY CO., LTD: Q1 2024 Earnings Release
27/04/2024 TONGHUA DONGBAO PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
26/04/2024 SHENZHEN WEIGUANG BIOLOGICAL PRODUCTS CO., LTD.: Q1 2024 Earnings Release
26/04/2024 SHANGHAI OPM BIOSCIENCES CO., LTD.: Q1 2024 Earnings Release (Projected)
26/04/2024 LIAONING CHENGDA BIOTECHNOLOGY CO.,LTD.: Q1 2024 Earnings Release (Projected)
26/04/2024 HUALAN BIOLOGICAL VACCINE INC.: Q1 2024 Earnings Release
26/04/2024 HUALAN BIOLOGICAL ENGINEERING INC.: Q1 2024 Earnings Release

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. SPEX Stock
  4. Calendar Spexis AG